The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
103928638 10392863 8 F 1997 20160721 20140819 20160728 EXP US-009507513-1408USA005658 MERCK 0.00 F Y 48.53000 KG 20160728 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
103928638 10392863 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral UNK U 20560 TABLET
103928638 10392863 2 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW U 20560 70 MG TABLET /wk
103928638 10392863 3 SS FOSAMAX PLUS D ALENDRONATE SODIUMCHOLECALCIFEROL 1 Oral 70/2800 MG QW 0 TABLET /wk
103928638 10392863 4 SS FOSAMAX PLUS D ALENDRONATE SODIUMCHOLECALCIFEROL 1 Oral 70/2800 QW 0 TABLET /wk
103928638 10392863 5 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 0 70 MG /wk
103928638 10392863 6 C VITAMINS (UNSPECIFIED) VITAMINS 1 Unknown 1 TABLET, QD U 0 1 DF QD
103928638 10392863 7 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 0.112 MG, QD U 0 .112 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
103928638 10392863 1 Osteoporosis
103928638 10392863 3 Osteoporosis
103928638 10392863 5 Osteoporosis
103928638 10392863 6 Product used for unknown indication
103928638 10392863 7 Hypothyroidism

Outcome of event

Event ID CASEID OUTC COD
103928638 10392863 HO
103928638 10392863 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
103928638 10392863 Arthritis
103928638 10392863 Blood thyroid stimulating hormone increased
103928638 10392863 Body height decreased
103928638 10392863 Breast cancer
103928638 10392863 Calcium deficiency
103928638 10392863 Dental prosthesis placement
103928638 10392863 Facial paralysis
103928638 10392863 Fall
103928638 10392863 Femur fracture
103928638 10392863 Hip arthroplasty
103928638 10392863 Hyperlipidaemia
103928638 10392863 Jaw disorder
103928638 10392863 Joint stiffness
103928638 10392863 Migraine with aura
103928638 10392863 Packed red blood cell transfusion
103928638 10392863 Pain in extremity
103928638 10392863 Radiotherapy
103928638 10392863 Sacroiliitis
103928638 10392863 Scoliosis
103928638 10392863 Seasonal allergy
103928638 10392863 Spinal osteoarthritis
103928638 10392863 Varicella
103928638 10392863 Vertigo

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
103928638 10392863 1 199509 0
103928638 10392863 2 20061120 20071119 0
103928638 10392863 3 20071219 201002 0
103928638 10392863 4 201011 2012 0
103928638 10392863 5 201002 201011 0
103928638 10392863 6 1994 0
103928638 10392863 7 1984 0